Lucía González Cortijo
Hospital Universitario Quirónsalud Madrid(ES)Spanish Ovarian Cancer Research Group(ES)Universidad Europea de Madrid(ES)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)(2023)35 cited
- → Conservative management of patients with early endometrial carcinoma: a systematic review(2008)25 cited
- → ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma (039)(2023)8 cited
- → ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma(2025)7 cited
- → Addition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers(2018)5 cited
- → Comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in patients with newly diagnosed homologous recombination–deficient stage III/IV ovarian cancer: study protocol for cohort C of the open-label, phase 2, randomized controlled multicenter OPAL trial